Home RxNorm 1673566 bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment [Cuadriderma] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1673566
RxNorm name bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment [Cuadriderma]
Term type SBD
Status Active
Updated 2026-10-21 00:28:12 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 112015
Active start 112015
Multiple ingredient YES
Branded YES Ingredients And Strength# Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 58988-1170-1 58988-1170 Cuadriderma Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, and PRAMOXINE HYDROCHLORIDE ProMex LLC M004
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler M004 58988-1170 Cuadriderma Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, and PRAMOXINE HYDROCHLORIDE OTC MONOGRAPH DRUG ProMex LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.
NDC11, Source, Active table NDC11 Source Active 58988117001 rxnav_ndcs yes
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 Cuadriderma 500 UNT / 3.5 MG / 10,000 UNT / 10 MG per GM Topical Ointment [PSN] · bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment [Cuadriderma] [SBD] · Cuadriderma (bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG) per GM Topical Ointment [SY] 3 10 Cuadriderma ® 20220125
Recently Linked DailyMed Labels# Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC D04AB Anesthetics for topical use ATC1-4 pramoxine ATC S01AA Antibiotics ATC1-4 bacitracin ATC R02AB Antibiotics ATC1-4 bacitracin ATC A07AA Antibiotics ATC1-4 neomycin ATC A07AA Antibiotics ATC1-4 polymyxin B ATC S01AA Antibiotics ATC1-4 neomycin ATC R02AB Antibiotics ATC1-4 neomycin ATC S01AA Antibiotics ATC1-4 polymyxin B ATC S02AA Antiinfectives ATC1-4 polymyxin B ATC S03AA Antiinfectives ATC1-4 polymyxin B ATC B05CA Antiinfectives ATC1-4 neomycin ATC S03AA Antiinfectives ATC1-4 neomycin ATC S02AA Antiinfectives ATC1-4 neomycin ATC A01AB Antiinfectives and antiseptics for local oral treatment ATC1-4 neomycin ATC C05AD Local anesthetics ATC1-4 pramoxine ATC J01GB Other aminoglycosides ATC1-4 neomycin ATC J01XX Other antibacterials ATC1-4 bacitracin ATC D06AX Other antibiotics for topical use ATC1-4 bacitracin ATC D06AX Other antibiotics for topical use ATC1-4 neomycin ATC J01XB Polymyxins ATC1-4 polymyxin B FDASPL D000617 Aminoglycosides CHEM has_chemical_structure neomycin FDASPL N0000175477 Aminoglycoside Antibacterial EPC has_epc neomycin FDASPL N0000175499 Polymyxin-class Antibacterial EPC has_epc polymyxin B FDASPL N0000008479 Decreased Cell Wall Synthesis & Repair PE has_pe bacitracin MEDRT D001414 Bacitracin CHEM has_ingredient bacitracin MEDRT D009025 Morpholines CHEM has_ingredient pramoxine MEDRT D009025 Morpholines CHEM has_ingredient pramoxine hydrochloride MEDRT D009355 Neomycin CHEM has_ingredient neomycin MEDRT D011112 Polymyxin B CHEM has_ingredient polymyxin B MEDRT D016470 Bacteremia DISEASE may_treat polymyxin B MEDRT D001424 Bacterial Infections DISEASE may_prevent neomycin MEDRT D003877 Dermatitis, Contact DISEASE may_treat pramoxine MEDRT D003877 Dermatitis, Contact DISEASE may_treat pramoxine hydrochloride MEDRT D004342 Drug Hypersensitivity DISEASE ci_with neomycin MEDRT D004342 Drug Hypersensitivity DISEASE ci_with polymyxin B MEDRT D004342 Drug Hypersensitivity DISEASE ci_with bacitracin MEDRT D004342 Drug Hypersensitivity DISEASE ci_with pramoxine hydrochloride MEDRT D004342 Drug Hypersensitivity DISEASE ci_with pramoxine MEDRT D004653 Empyema DISEASE may_treat bacitracin MEDRT D004761 Enterocolitis, Pseudomembranous DISEASE may_treat bacitracin MEDRT D004927 Escherichia coli Infections DISEASE may_treat polymyxin B MEDRT D004927 Escherichia coli Infections DISEASE may_treat neomycin MEDRT D015818 Eye Infections, Bacterial DISEASE may_treat bacitracin MEDRT D015818 Eye Infections, Bacterial DISEASE may_treat polymyxin B MEDRT D005401 Fissure in Ano DISEASE may_treat pramoxine hydrochloride MEDRT D005401 Fissure in Ano DISEASE may_treat pramoxine MEDRT D005767 Gastrointestinal Diseases DISEASE may_treat polymyxin B MEDRT D006192 Haemophilus Infections DISEASE may_treat polymyxin B MEDRT D006484 Hemorrhoids DISEASE may_treat pramoxine hydrochloride MEDRT D006484 Hemorrhoids DISEASE may_treat pramoxine MEDRT D006501 Hepatic Encephalopathy DISEASE may_treat neomycin MEDRT D015212 Inflammatory Bowel Diseases DISEASE ci_with neomycin MEDRT D007415 Intestinal Obstruction DISEASE ci_with neomycin MEDRT D007674 Kidney Diseases DISEASE ci_with bacitracin MEDRT D007710 Klebsiella Infections DISEASE may_treat polymyxin B MEDRT D016920 Meningitis, Bacterial DISEASE may_treat polymyxin B MEDRT D010032 Otitis Externa DISEASE may_treat polymyxin B MEDRT D010146 Pain DISEASE may_treat pramoxine MEDRT D010146 Pain DISEASE may_treat pramoxine hydrochloride MEDRT D011014 Pneumonia DISEASE may_treat bacitracin MEDRT D011537 Pruritus DISEASE may_treat pramoxine MEDRT D011537 Pruritus DISEASE may_treat pramoxine hydrochloride MEDRT D011552 Pseudomonas Infections DISEASE may_treat polymyxin B MEDRT D012871 Skin Diseases DISEASE may_treat polymyxin B MEDRT D017192 Skin Diseases, Bacterial DISEASE may_treat bacitracin MEDRT D017192 Skin Diseases, Bacterial DISEASE may_prevent bacitracin MEDRT D017192 Skin Diseases, Bacterial DISEASE may_treat neomycin MEDRT D018461 Soft Tissue Infections DISEASE may_treat polymyxin B MEDRT D013203 Staphylococcal Infections DISEASE may_treat bacitracin MEDRT D013290 Streptococcal Infections DISEASE may_treat bacitracin MEDRT D001745 Urinary Bladder Diseases DISEASE may_treat polymyxin B MEDRT D014947 Wounds and Injuries DISEASE may_treat polymyxin B MEDRT N0000000226 Acid-Base Activity MOA has_moa polymyxin B MEDRT N0000009954 Cell Membrane Fusion Complex Interactions MOA has_moa bacitracin MEDRT N0000000227 Cholinergic Nicotinic Antagonists MOA ci_moa polymyxin B MEDRT N0000000163 Enzyme Interactions MOA has_moa bacitracin MEDRT N0000000150 Protein Synthesis Inhibitors MOA has_moa neomycin MEDRT N0000009915 Unknown Cellular or Molecular Interaction MOA has_moa pramoxine MEDRT N0000009915 Unknown Cellular or Molecular Interaction MOA has_moa pramoxine hydrochloride MEDRT N0000008346 Cellular Structure Alteration PE has_pe polymyxin B MEDRT N0000008479 Decreased Cell Wall Synthesis & Repair PE has_pe bacitracin MEDRT N0000008841 Decreased Protein Synthesis PE has_pe neomycin MEDRT N0000008889 Decreased Sensory-Somatic Nervous System Organized Electrical Activity PE has_pe pramoxine MEDRT N0000008889 Decreased Sensory-Somatic Nervous System Organized Electrical Activity PE has_pe pramoxine hydrochloride MEDRT N0000008953 Decreased Striated Muscle Contraction PE ci_pe polymyxin B
Properties# Category, Property, Value table Category Property Value ATTRIBUTES ACTIVATED 11/26/2024 ATTRIBUTES AVAILABLE_STRENGTH 0.5 UNT/MG / 0.0035 MG/MG / 10 UNT/MG / 0.01 MG/MG ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US NAMES Prescribable Synonym Cuadriderma 500 UNT / 3.5 MG / 10,000 UNT / 10 MG per GM Topical Ointment SOURCES Source Metathesaurus FDA Structured Product Labels